HIV-1 INDUCES G2/M CELL CYCLE ARREST
HIV-1 INDUCES G2/M CELL CYCLE ARREST
批准号:
2414444
负责人:
IRVIN S.Y. CHEN
金额:
$28.84万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-07-18 至 1998-07-16
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Various mechanisms have been proposed to account for the immune
dysfunction in AIDS ultimately leading to loss of CD4+ T-cells, including
envelope-mediated syncytium formation, apoptosis and cytokine modulation.
Our recent results suggest a novel hypothesis forT-cell dysfunction. We
used a human immunodeficiency virus type 1 (HIV-1) bearing a novel cell
surface reporter gene, murine thy 1.2, to distinguish infected from
uninfected cells in the same population. We show that infected cells,
both from cell lines and primary T-cells, are unable to progress normally
through the cell cycle and become arrested in the G2/M phase. One of the
HIV-1 genes, vpr, has been implicated in a number of functions, including
trans-activation, nuclear targeting and re-activation of latent HIV-1.
We demonstrate that the arrest of cell growth can be attributed to the
vpr gene product of HIV-1, as mutation of this gene allows cell cycle
progression of the infected cells. Furthermore, by transient transfection
assays, we show that expression of vpr alone will induce cell cycle
arrest in SupT1 T-cells and HeLa cells. Using a different reporter
system, luciferase, we investigate the consequences of G2 arrest for HIV-
1 replication. Our results show that the HIV-1 provirus is not maintained
due to the selective growth disadvantage of infected cells. Mutation of
vpr results in maintenance of infection. Thus, expression of vpr prevents
the establishment of a chronic HIV-1 infection. These results have two
predictions that are relevant to HIV-1 pathogenesis: 1) that HIV-1
infection does not generally lead to a chronic infection with persistence
of provirus; and 2) that infected T-cells would be unable to undergo
clonal expansion as a result of G2/M arrest, with consequences for immune
dysfunction. We propose here to extend our initial findings to develop
further insights into its mechanism of action.
The Specific Aims are to:
1. Determine the relationship between the G2/M arrest phenotype and
other observed functions of the vpr gene. Structure-function
relationships will be investigated through genetic approaches.
2. Compare the functions of vpr-related genes from HIV-1, HIV-2 and
simian immunodeficiency virus (SIV) in regards to cell cycle arrest. We
will also compare the functions of Vpr with those of the evolutionarily
conserved vpx gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10160815
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Administrative Core
-
批准号:10614634
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:10468647
-
项目类别:
-
资助金额:$284.77万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:10614633
-
项目类别:
-
资助金额:$284.81万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:10160814
-
项目类别:
-
资助金额:$284.79万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:9890819
-
项目类别:
-
资助金额:$287.22万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Administrative Core
-
批准号:10468648
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
In Vivo Gene Editing for HIV-1 Cure
-
批准号:10549758
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2019
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
In Vivo Gene Editing for HIV-1 Cure
-
批准号:10331787
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2019
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
In Vivo Gene Editing for HIV-1 Cure
-
批准号:9753575
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2019
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Anti-HIV Gene Therapy: Defend and Attack
-
批准号:8899031
-
项目类别:
-
资助金额:$225.61万
-
财政年份:2015
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Anti-HIV Gene Therapy: Defend and Attack
-
批准号:9468343
-
项目类别:
-
资助金额:$195.65万
-
财政年份:2015
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Anti-HIV Gene Therapy: Defend and Attack
-
批准号:9249485
-
项目类别:
-
资助金额:$213.55万
-
财政年份:2015
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:9264595
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Mouse and mathematical models for HIV-1 suppression through HSPC
-
批准号:8915902
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:9058597
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:8906934
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Gene engineering using CRISPR/Cas9 mutagenesis to eliminate latent HIV-1
-
批准号:8789998
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:8790285
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Hematopoietic stem/progenitor cell reservoirs
-
批准号:8659761
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2013
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
海外基金